Amicus Therapeutics Inc (FOLD)

9.63 -0.14 (-1.43%) USD  |  NASDAQ  |  Dec 27, 16:00
9.635 0.00 (0.00%) After-Hours: 20:00
More

Amicus Therapeutics Research and Development Expense (Quarterly): 26.16M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for FOLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Tonix Pharmaceuticals Holding Corp 9.114M
Immuneering Corp 11.25M
Halozyme Therapeutics Inc 18.46M
Alnylam Pharmaceuticals Inc 270.93M
Insmed Inc 150.81M